Schroder Investment Management Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,500,183
| Closed | -$22.7M | – | 1345 |
|
|
2022
Q3 | $22.7M | Sell |
1,500,183
-594,628
| -28% | -$6.91M | 0.04% | 412 |
|
|
2022
Q2 | $15.7M | Sell |
2,094,811
-257,183
| -11% | -$1.81M | 0.02% | 533 |
|
|
2022
Q1 | $21.4M | Buy |
2,351,994
+999,040
| +74% | +$7.7M | 0.03% | 481 |
|
|
2021
Q4 | $9.5M | Buy |
1,352,954
+19,990
| +1% | +$209K | 0.01% | 619 |
|
|
2021
Q3 | $15.2M | Sell |
1,332,964
-66,381
| -5% | -$970K | 0.02% | 537 |
|
|
2021
Q2 | $22.4M | Sell |
1,399,345
-12,109
| -0.9% | -$208K | 0.03% | 490 |
|
|
2021
Q1 | $25.2M | Buy |
1,411,454
+8,479
| +0.6% | +$146K | 0.03% | 447 |
|
|
2020
Q4 | $19M | Buy |
1,402,975
+257,300
| +22% | +$3.11M | 0.03% | 496 |
|
|
2020
Q3 | $13.7M | Buy |
1,145,675
+29,637
| +3% | +$361K | 0.02% | 516 |
|
|
2020
Q2 | $16.5M | Buy |
1,116,038
+13,435
| +1% | +$199K | 0.03% | 449 |
|
|
2020
Q1 | $13.2M | Buy |
1,102,603
+267
| +0% | +$5.07K | 0.03% | 473 |
|
|
2019
Q4 | $26.6M | Buy |
+1,102,336
| New | +$22.8M | 0.04% | 428 |
|
|
2016
Q1 | – | Sell |
-471,000
| Closed | -$11.5M | – | 1245 |
|
|
2015
Q4 | $11.5M | Buy |
471,000
+51,500
| +12% | +$1.2M | 0.02% | 597 |
|
|
2015
Q3 | $7.44M | Sell |
419,500
-765,800
| -65% | -$13.9M | 0.02% | 659 |
|
|
2015
Q2 | $20.4M | Buy |
1,185,300
+709,600
| +149% | +$13M | 0.04% | 463 |
|
|
2015
Q1 | $14.7M | Buy |
475,700
+95,500
| +25% | +$2.77M | 0.03% | 558 |
|
|
2014
Q4 | $11.1M | Sell |
380,200
-23,900
| -6% | -$606K | 0.02% | 619 |
|
|
2014
Q3 | $8.36M | Hold |
404,100
| – | – | 0.01% | 703 |
|
|
2014
Q2 | $10M | Buy |
404,100
+2,400
| +0.6% | +$41.6K | 0.01% | 636 |
|
|
2014
Q1 | $8.51M | Sell |
401,700
-15,900
| -4% | -$321K | 0.01% | 667 |
|
|
2013
Q4 | $7.5M | Buy |
+417,600
| New | +$5.44M | 0.01% | 719 |
|
Schroder Investment Management Group's AERI Position: Q4 2022 in Review
Schroder Investment Management Group sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,500,183 shares — an estimated $22.7M sold.
Schroder Investment Management Group first reported a position in AERI in Q4 2013 and held it in 21 quarters. The position peaked at $26.6M in Q4 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Schroder Investment Management Group reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Schroder Investment Management Group sold 1,500,183 Aerie Pharmaceuticals shares in Q4 2022, an estimated $22.7M.
- Schroder Investment Management Group first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 21 quarters.
- Schroder Investment Management Group's Aerie Pharmaceuticals position peaked at $26.6M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Schroder Investment Management Group's 13F filing for Q4 2022, filed 10 Feb 2023.